Correlation Between Agilent Technologies and Entrada Therapeutics
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and Entrada Therapeutics, you can compare the effects of market volatilities on Agilent Technologies and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and Entrada Therapeutics.
Diversification Opportunities for Agilent Technologies and Entrada Therapeutics
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Agilent and Entrada is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and Entrada Therapeutics go up and down completely randomly.
Pair Corralation between Agilent Technologies and Entrada Therapeutics
Taking into account the 90-day investment horizon Agilent Technologies is expected to generate 2.55 times less return on investment than Entrada Therapeutics. But when comparing it to its historical volatility, Agilent Technologies is 1.3 times less risky than Entrada Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest 1,714 in Entrada Therapeutics on September 1, 2024 and sell it today you would earn a total of 275.00 from holding Entrada Therapeutics or generate 16.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agilent Technologies vs. Entrada Therapeutics
Performance |
| Timeline |
| Agilent Technologies |
| Entrada Therapeutics |
Agilent Technologies and Entrada Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agilent Technologies and Entrada Therapeutics
The main advantage of trading using opposite Agilent Technologies and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.| Agilent Technologies vs. Verve Therapeutics | Agilent Technologies vs. Beam Therapeutics | Agilent Technologies vs. Caribou Biosciences | Agilent Technologies vs. Sana Biotechnology |
| Entrada Therapeutics vs. Molecular Partners AG | Entrada Therapeutics vs. Pmv Pharmaceuticals | Entrada Therapeutics vs. Monte Rosa Therapeutics | Entrada Therapeutics vs. Vigil Neuroscience |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |